Search

Background: Caffeine is a widely recognized ergogenic aid for enhancing exercise performance. However, its effect on throwing performance has been less studied, yielding contradictory results. Objectives: The main aim of the study was to analyze the potential ergogenic effects of a moderate dose of caffeine (3 mg·kg−1 body mass) on vertical jump performance and throwing distance during a simulated competition in trained discus and hammer throwers. Methods: In a randomized, counterbalanced, and repeated measures design, 14 well-trained throwers (9 hammer throwers and 5 discus throwers; age 24.8 ± 6.3 years old, training 14.9 ± 5.0 h per week, competing experience 10.5 ± 6.1 years) performed a countermovement jump (CMJ) test, a modified throw, and a complete throw after the ingestion of 3 mg·kg⁻¹ body mass of caffeine or a placebo. Each participant performed three maximal-effort valid modified throws of his/her respective event (i.e., hammer or discus throw), plus three maximal-effort valid official throws (up to five tries, respectively, in case any attempt was called as foul). Throwing distance was measured according to World Athletics regulations using a metal tape, while release speed was assessed with a radar device. After the performance measurements, participants completed a form about side effects prevalence. Results: Caffeine, compared to placebo, increased throw distance (3.0 ± 5.1%, p = 0.048) and speed release (5.7 ± 8.7%, p = 0.03) for the complete throw, and distance (3.6 ± 4.4%, p = 0.01) and speed release (4.8 ± 7.4 %, p = 0.01) for the modified throw. Caffeine ingestion did not significantly improve jump height (1.1 ± 4.3%, p = 0.28), although it improved force and power on braking and the propulsive phases of the CMJ (p < 0.05). Caffeine only increased the prevalence of activeness (p < 0.05). Conclusions: An acute moderate dose of caffeine enhanced hammer and discus throw performance in well-trained throwers during a simulated competitive setting, with minimal adverse side effects. [ABSTRACT FROM AUTHOR]

Understanding the reliability of jump testing is essential to determine the neuromuscular progress of athletes and make informed decisions. This study aimed to assess the reliability of several countermovement jump (CMJ) and drop jump (DJ) test metrics in female volleyball players. Sixteen (n = 16) semi-professional female volleyball players participated in this test-retest study. Intrasession and intersession reliability of CMJ and DJ metrics were evaluated using a randomized cross-over design. A dual force platform was used to collect CMJ and DJ data, and several dependent variables were calculated using forward dynamics. Intraclass correlation coefficients (ICC), coefficients of variation (CV), and minimum difference (MD) were calculated to assess intra- and interday reliability. During the same testing, the third attempt consistently yielded the highest values for both tests in jump height but presented excellent reliability (CMJ: ICC [95%CI] = 0.97 [0.93–0.99]; CV [95%CI] = 4.1% [1.2–7.0]; MD95 = 3.5 cm; MD90 = 2.9 cm; DJ: ICC [95%CI] = 0.91 [0.77–0.97]; CV [95%CI] = 6.7% [1.9–11.5]; MD95 = 6.0 cm; MD90 = 5.0 cm). CMJ height exhibited excellent reliability between sessions (ICC [95%CI] = 0.93 [0.81–0.97]; CV [95%CI] = 3.8% [1.1–6.4]; MD95 = 3.5 cm; MD90 = 3.0 cm), whereas DJ height demonstrated slightly lower but still acceptable intersession reliability (ICC [95%CI] = 0.81 [0.55–0.93]; CV [95%CI] = 6.1% [1.7–10.4]; MD95 = 5.2 cm; MD90 = 4.4 cm). Intersession reliability for CMJ kinetics and kinematics was excellent for 13 of the 24 metrics assessed. For DJ, only concentric (ICC [95%CI] = 0.91 [0.76–0.97]; CV [95%CI] = 3.0% [0.9–5.2]; MD95 = 15 Ns; MD90 = 12.6 Ns) and eccentric impulses (ICC [95%CI] = 0.99 [0.96–0.99]; CV [95%CI] = 1.7% [0.5–2.9]; MD95 = 9.2 Ns; MD90 = 7.7 Ns) demonstrated excellent intersession reliability. Most CMJ variables showed excellent reliability within sessions, while DJ had lower reliability in most metrics. These findings provide valuable information to physical trainers to select the metrics to assess athletes' performance as well as to identify a minimum cut-off value that serves as a reference for each of the metrics reported in both tests. [ABSTRACT FROM AUTHOR]

The aim of this study was to investigate the effect of 3 and 6 mg of caffeine per kg of body mass (mg/kg) on whole-body substrate oxidation during an incremental cycling exercise test in healthy active women. Using a double-blind placebo-controlled counterbalanced experimental design, 14 subjects performed three identical exercise trials after the ingestion of 3 or 6 mg/kg of caffeine or placebo. The exercise trials consisted of an incremental test on a cycle ergometer with 3-min stages at workloads from 30 to 70% of maximal oxygen uptake (VO2max). Substrate oxidation rates were measured by indirect calorimetry. During exercise, there was a significant effect of substance (F = 5.221; p = 0.016) on fat oxidation rate. In comparison to the placebo, 3 mg/kg of caffeine increased fat oxidation rates at 30 to 60% of VO2max (all p < 0.050) and 6 mg/kg at 30 to 50% of VO2max (all p < 0.050). There was also a significant effect of substance (F = 5.221; p = 0.016) on carbohydrate oxidation rate (F = 9.632; p < 0.001). In comparison to placebo, both caffeine doses decreased carbohydrate oxidation rates at 40 to 60% VO2max (all p < 0.050). The maximal rate of fat oxidation with placebo was 0.24 ± 0.03 g/min, which increased with 3 mg/kg to 0.29 ± 0.04 g/min (p = 0.032) and to 0.29 ± 0.03 with 6 mg/kg of caffeine (p = 0.042). Acute intake of caffeine improves the utilization of fat as a fuel during submaximal aerobic exercise in healthy active women with an effect of similar magnitude after the intake of 3 and 6 mg of caffeine per kg of body mass. Thus, the use of 3 mg/kg of caffeine would be more recommended than 6 mg/kg for women seeking increased fat utilization during submaximal exercise. [ABSTRACT FROM AUTHOR]

Maximal fat oxidation during exercise (MFO) and the intensity that elicits MFO (Fatmax) seems to show a diurnal variation in men, which favours an increased performance in the afternoon than the morning. At present, it remains unknown whether the observed MFO and Fatmax diurnal variation in men is also present in women. Therefore, the current study examined the diurnal variations of MFO and Fatmax in women. Nineteen healthy women (age: 26.9 ± 8.7 years, maximum oxygen uptake: 39.8 ± 6.5 ml/kg/min) participated in the study. MFO and Fatmax were determined by a graded exercise test in cycloergometer using a cross-over design performed on two separate daytime schedules, one conducted in the morning (8am–11am) and one in the afternoon (5pm–8pm). Stoichiometric equations were used to calculate fat oxidation rates. There were no significant differences between MFO-morning and MFO-afternoon (0.24 ± 0.10 vs. 0.23 ± 0.07 g/min, respectively; P = 0.681). Similarly, there was no significant differences between Fatmax-morning and Fatmax-afternoon (41.1 ± 4.7 vs. 42.6 ± 5.5% of maximal oxygen uptake, respectively; P = 0.305). These results persisted after controlling for fat mass percentage (all P > 0.5). In summary, the main finding of the present study was that MFO and Fatmax were similar independent of the time-of-day when the exercise test is performed in healthy women. These results have important clinical implications since they suggest that, in contrast to what was found in men, MFO and Fatmax show similar rates during the course of the day in women. Highlights MFO and Fatmax were similar during the afternoon and morning in young healthy women. Our results suggest that, in women, it does not matter when endurance exercise is performed in term of fat metabolism during exercise. [ABSTRACT FROM AUTHOR]

Aim: (i) to compare the effects of two different low-volume resistance priming sessions, where the external load is modified on neuromuscular performance after 6 h of rest; and (ii) to identify the effects on psychological readiness in participants with resistance training experience. Methods: Eleven participants (Body mass: 77.0 ± 8.9 kg; Body height: 1.76 ± 0.08 m; Half squat repetition maximum: 139.8 ± 22.4 kg) performed the priming session under three experimental conditions in a randomized and cross-over design during the morning. The control (CON) condition: no resistance training, "optimal load" (OL) condition: two half-squat sets with a velocity loss of around 20% were performed with the "optimal load", and 80% of repetition maximum (80% RM) condition: 2 half-squat sets with a velocity loss of around 20% were performed with the 80% RM. Countermovement jump (CMJ), mean power with OL (MPOL) and 80% RM (MP80RM), and mean velocity with OL (MVOL) and 80% RM (MV80RM) were assessed six hours after the intervention. Subjective readiness was also recorded prior to resistance training and evaluation. Significance was set at p < 0.05. Results: CMJ was higher after the 80% RM intervention than CON (p < 0.001; Δ = 6.5% [3.4–9.5]). MPOL and MVOL seemed to be unaffected by both morning sessions. Higher MP80RM (p = 0.044; Δ = 9.7% [4.0–15.6]; d = 0.24[0.10–0.37]) and MV80RM (p = 0.004; Δ = 8.1% [3.2–13.3]; d = 0.32[0.13–0.52]) after 80% RM than after CON were observed. No effect was observed on psychological readiness. Conclusions: 80% RM priming session increased CMJ height and the capacity to generate power and velocity under a high-load condition without any effect on psychological readiness. [ABSTRACT FROM AUTHOR]

The aim of this study was to investigate the acute effects of p-synephrine ingestion on substrate oxidation during exercise in elite cyclists. Fifteen elite cyclists volunteered to participate in a double blind, crossover, randomized and placebo-controlled experimental trial. During two different trials, participants either ingested a placebo (cellulose) or 3 mg/kg of p-synephrine. After 60 min for substances absorption, participants performed an incremental maximal cycle ergometer test until volitional fatigue (25 W/min). Breath-by-breath gas exchange data was continuously recorded during the entire test to estimate energy expenditure, carbohydrate oxidation, and fat oxidation rates by stoichiometric equations. Heart rate was continuously measured by using a heart rate monitor. The ingestion of p-synephrine had no significant effects on energy expenditure (F = 0.71, P = 0.40) or heart rate (F = 0.66, P = 0.43) during exercise. However, there was a main effect of p-synephrine to increase the rate of fat oxidation over the placebo (F = 5.1, P = 0.04) and the rate of fat oxidation was higher with p-synephrine in the following loads: 45 ± 2%, 51 ± 3%, 62 ± 3%, 67 ± 4%, 79 ± 5% and 85 ± 5% of the maximum wattage obtained in the test (all P < 0.05). The ingestion of p-synephrine did not modify the maximal rate of fat oxidation during the ramp test (mean value; 95%CI = 0.91; 0.79–1.03 vs 1.01; 0.91–1.11 g/min, respectively, P = 0.06) nor the exercise intensity at which maximal fat oxidation was achieved (i.e. Fatmax = 49; 48–53 vs 50; 47–51% Wmax, P = 0.52). Acute p-synephrine ingestion moved the fat oxidation-exercise intensity curve upwards during an incremental cycling test without affecting Fatmax. [ABSTRACT FROM AUTHOR]

Aim: The objective of this current research was to compare fat oxidation rates during an incremental cycling exercise test in a temperate vs. hot environment. Methods: Twelve healthy young participants were recruited for a randomised crossover experimental design. Each participant performed a VO2max test in a thermoneutral environment followed by two cycling ramp test trials, one in a temperate environment (18.3°C) and another in a hot environment (36.3°C). The ramp test consisted of 3-min stages of increasing intensity (+10% of VO2max) while gas exchange, heart rate and perceived exertion were measured. Results: During exercise, there was a main effect of the environment temperature on fat oxidation rate (F = 9.35, P = 0.014). The rate of fat oxidation was lower in the heat at 30% VO2max (0.42 ± 0.15 vs.0.37 ± 0.13 g/min; P = 0.042), 60% VO2max (0.37 ± 0.27 vs.0.23 ± 0.23 g/min; P = 0.018) and 70% VO2max (0.22 ± 0.26 vs.0.12 ± 0.26 g/min; P = 0.007). In addition, there was a tendency for a lower maximal fat oxidation rate in the heat (0.55 ± 0.2 vs.0.48 ± 0.2 g/min; P = 0.052) and it occurred at a lower exercise intensity (44 ± 14 vs.38% ± 8% VO2max; P = 0.004). The total amount of fat oxidised was lower in the heat (5.8 ± 2.6 vs 4.6 ± 2.8 g; P = 0.002). The ambient temperature also produced main effects on heart rate (F = 15.18, P = 0.005) and tympanic temperature (F = 25.23, P = 0.001) with no effect on energy expenditure (F = 0.01, P = 0.945). Conclusion: A hot environment notably reduced fat oxidation rates during a ramp exercise test. Exercising in the heat should not be recommended for those individuals seeking to increase fat oxidation during exercise. [ABSTRACT FROM AUTHOR]

Purpose: Recent investigations have established that the ingestion of a moderate dose of caffeine (3–6 mg kg−1) can increase exercise and sports performance in women. However, it is unknown whether the ergogenicity of caffeine is similar during all phases of the menstrual cycle. The aim of this investigation was to determine the ergogenic effects of caffeine in three phases of the menstrual cycle. Methods: Thirteen well-trained eumenorrheic triathletes (age = 31 ± 6 years; body mass = 58.6 ± 7.8 kg) participated in a double-blind, cross-over, randomised experimental trial. In the (1) early follicular (EF); (2) preovulation (PO); (3) and mid luteal (ML) phases, participants either ingested a placebo (cellulose) or 3 mg kg−1 of caffeine in an opaque and unidentifiable capsule. After a 60-min wait for substance absorption, participants performed an incremental maximal cycle ergometer test until volitional fatigue (25 W/min) to assess peak aerobic cycling power (Wmax). Results: In comparison to the placebo, caffeine increased Wmax in the EF (4.13 ± 0.69 vs. 4.24 ± 0.71 W kg−1, Δ = 2.7 ± 3.3%, P = 0.01), in the PO (4.14 ± 0.70 vs. 4.27 ± 0.73 W kg−1, Δ = 3.3 ± 5.0%; P = 0.03) and in the ML (4.15 ± 0.69 vs. 4.29 ± 0.67 W kg−1, Δ = 3.6 ± 5.1%; P = 0.01) phases. The magnitude of the caffeine ergogenic effect was similar during all of the menstrual cycle phases (P = 0.85). Conclusion: Caffeine increased peak aerobic cycling power in the early follicular, preovulatory, and mid luteal phases. Thus, the ingestion of 3 mg of caffeine per kg of body mass might be considered an ergogenic aid for eumenorrheic women during all three phases of the menstrual cycle. [ABSTRACT FROM AUTHOR]

The aim of this investigation was to determine the effects different doses of p-synephrine on maximal fat oxidation during exercise. Seventeen healthy subjects volunteered to participate in a double-blind and randomised experimental design composed of four identical experimental trials. On four trials separated by 72 h, participants ingested a placebo or 1, 2 or 3 mg/kg of p-synephrine. After resting for 60 min to allow substance absorption, participants performed an exercise test of increasing intensity on a cycle ergometer while gas exchange was measured continuously. None of the doses of p-synephrine affected energy expenditure or heart rates during the test. The highest rate of fat oxidation with the placebo (0.35 ± 0.05 g/min) was reached at 38.0 ± 1.9% of VO2max . The ingestion of 1 mg/kg increased maximal fat oxidation to 0.47 ± 0.11 g/min (p = 0.01) but did not change the intensity at which it was obtained (42.0 ± 9.4% of VO2max ). The ingestion of 2 and 3 mg/kg of p-synephrine increased maximal fat oxidation to 0.55 ± 0.14 g/min (p < 0.01), although only 3 mg/kg slightly changed the intensity at which it was obtained (43.0 ± 9.5% of VO2max , p < 0.01). In conclusion, although all p-synephrine increased the maximal rate of fat oxidation during exercise, the highest effects were found with 2 and 3 mg/kg. Copyright © 2017 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]